|
GALXC
Filed on: 2/17/2021
|
Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; drug delivery agents consisting of a biological compound in the form of a molecular c...
read more...
|
NOTICE OF ALLOWANCE - ISSUED
3/12/2024
|
|
|
GALXC
Filed on: 2/17/2021
|
Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; drug delivery agents consisting of a biological compound in the form of a molecular c...
read more...
|
NOTICE OF ALLOWANCE - ISSUED
3/12/2024
|
|
|
GALXC
Filed on: 1/27/2017
|
Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide delivery agents for use in targeted pharmaceutical therapies for...
read more...
|
ABANDONED - NO STATEMENT OF USE FILED
3/22/2021
|
|
|
GALXC
Filed on: 1/27/2017
|
Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide delivery agents for use in targeted pharmaceutical therapies for...
read more...
|
ABANDONED - NO STATEMENT OF USE FILED
3/22/2021
|
|
|
GALXC
Filed on: 6/30/2016
|
Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; Biological compound in the form of a molecular complex that acts as a platform for th...
read more...
|
ABANDONED - NO STATEMENT OF USE FILED
3/29/2021
|
|